Midori Hirai
- Pharmacology top 0.5%
- Pharmacy and Medical Practices 16
- Pharmacogenetics and Drug Metabolism 6
- Oncology top 2%
- Drug Transport and Resistance Mechanisms 13
- Cytokine Signaling Pathways and Interactions 5
-
- Pharmacological Effects and Toxicity Studies 6
- Geriatrics and Gerontology top 5%
- Pharmaceutical Practices and Patient Outcomes 11
-
- Safe Handling of Antineoplastic Drugs 7
-
- Signaling Pathways in Disease 5
- Co-authors
- Noboru OkamuraYusuke TanigawaraKazumitsu UedaTohru KomanoNoriyuki KiokaTakashi SaekiRyusuke HoriMasato Yasuhara
- Partner nations
- JapanUnited StatesNew Zealand
In The Last Decade
Midori Hirai
100 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Pharmacology 452
- Oncology 1.4k
- Pediatrics, Perinatology and Child Health 755
- Complementary and alternative medicine 250
- Geriatrics and Gerontology 92
Countries citing papers authored by Midori Hirai
This map shows the geographic impact of Midori Hirai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Midori Hirai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Midori Hirai more than expected).
Fields of papers citing papers by Midori Hirai
This network shows the impact of papers produced by Midori Hirai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Midori Hirai. The network helps show where Midori Hirai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Midori Hirai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 0 | |
| 2 | 2013 | 3 | |
| 3 | 2013 | 6 | |
| 4 | 2011 | 1 | |
| 5 | 2009 | 33 | |
| 6 | 2008 | 8 | |
| 7 | 2008 | 4 | |
| 8 | 2006 | 7 | |
| 9 | 2004 | 7 | |
| 10 | 2004 | 11 | |
| 11 | 2003 | 0 | |
| 12 | 2003 | 7 | |
| 13 | 2002 | 5 | |
| 14 | Chitosan Induces Apoptosis via Caspase-3 Activation in Bladder Tumor Cells | 2001 | 1 |
| 15 | 2001 | 5 | |
| 16 | 2001 | 121 | |
| 17 | 2001 | 267 | |
| 18 | 1999 | 0 | |
| 19 | 1996 | 33 | |
| 20 | 1995 | 24 |
About Midori Hirai
Midori Hirai is a scholar working on Geriatrics and Gerontology, Pharmacology and Occupational Therapy, having authored 104 papers that have together received 3.1k indexed citations. Recurring topics across this work include Pharmacy and Medical Practices (16 papers), Drug Transport and Resistance Mechanisms (13 papers), Pharmaceutical Practices and Patient Outcomes (11 papers), Safe Handling of Antineoplastic Drugs (7 papers), Pharmacogenetics and Drug Metabolism (6 papers), Pharmacological Effects and Toxicity Studies (6 papers), Cytokine Signaling Pathways and Interactions (5 papers) and Signaling Pathways in Disease (5 papers). The work is most often cited by research in Pharmacology (452 citations), Oncology (1.4k citations) and Pediatrics, Perinatology and Child Health (755 citations). Midori Hirai has collaborated with scholars based in Japan, United States and New Zealand. Frequent co-authors include Noboru Okamura, Yusuke Tanigawara, Kazumitsu Ueda, Tohru Komano, Noriyuki Kioka, Takashi Saeki, Ryusuke Hori, Masato Yasuhara, Katsuhiko Okumura and Seigo Iwakawa.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.